The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

As per The Business Research Company’s Macular Degeneration Treatment Global Market Report 2023, the macular degeneration treatment market is expected to show significant growth in the forecast period.

Key insights from the macular degeneration treatment market forecast include:

1. Market Size

The worldwide macular degeneration treatment market is set to increase from $8.44 billion in 2022 to $9.43 billion in 2023, with a projected compound annual growth rate (CAGR) of 11.7%. The market’s size is anticipated to reach $14.3 billion in 2027, growing at a CAGR of 11.0%.

2. Major Driver

The growing prevalence of retinal disorders is set to drive the macular degeneration treatment market. A 2020 study in Tanzania found a 22.8% prevalence of vitreoretinal disorders among 1,007 participants, with leading disorders including age-related hypertensive macular scars (2.7%), retinopathy (4.5%), and degeneration (7.0%). The American Academy of Ophthalmology predicts that by 2050, around 7.32 million people in the United States will have primary open-angle glaucoma, with higher numbers in specific demographics. Consequently, the rising burden of retinal disorders fuels the growth of the macular degeneration treatment market.

View More On The Macular Degeneration Treatment Market Report 2023 – https://www.thebusinessresearchcompany.com/report/macular-degeneration-treatment-global-market-report

3. Key Trend

The emergence of advanced therapies is a prominent trend in the macular degeneration treatment market. Advanced therapies, including gene therapy, have made significant strides, especially in addressing inherited retinal diseases. Notably, in October 2021, Genentech, a US-based biotechnology company, gained FDA approval for Susvimo, a novel treatment for wet age-related macular degeneration. Susvimo represents a breakthrough by providing an alternative to frequent eye injections that have been the standard of care for the past 15 years. It offers the potential for people with wet AMD to maintain their vision with as few as two treatments annually through a refillable implant that continuously administers medication into the eye.

4. Largest Region

North America will be the largest region in the macular degeneration treatment market.

5. Major Players

Major players in the food diagnostics market are Novartis AG, Bausch Health Companies Inc., Regenxbio Inc., F Hoffmann-La Roche Ltd., Regeneron Pharmaceuticals Inc., GlaxoSmithKline plc, Bayer AG, Neurotech Pharmaceuticals Inc., Ophthotech Corporation, StemCells Inc., Pfizer Inc., Santen Pharmaceuticals, Alimera Sciences Inc., Aerie Pharmaceutical Inc., Panoptica, Allergan Inc., Valeant Pharmaceuticals, and Rxi Pharmaceuticals Inc.

Request A Sample Of The Global Macular Degeneration Treatment Market Report 2023:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5799&type=smp

Key Macular Degeneration Treatment Market Segments
The global macular degeneration treatment market is segmented –
1) By Stage of Disease: Early-Stage AMD, Intermediate AMD, Late-Stage AMD
2) By End User: Ambulatory Surgical Centers, Ophthalmic Clinics, Hospitals
3) By Route of Administration: Oral, Injectable, Other Route of Administration
4) By Types: Wet Macular Degeneration, Dry Macular Degeneration

The Macular Degeneration Treatment Global Market Report 2023  provides an in-depth analysis on the macular degeneration treatment market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the macular degeneration treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

View More Related Reports –
Age-Related Macular Degeneration Global Market Report 2023
Ophthalmic Medical Lasers Global Market Report 2023
Ocular Drug Delivery Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model